Jentadueto is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Linagliptin; Metformin Hydrochloride.
Product ID | 0597-0146_08aba537-6118-a213-5811-ef56e20300bd |
NDC | 0597-0146 |
Product Type | Human Prescription Drug |
Proprietary Name | Jentadueto |
Generic Name | Linagliptin And Metformin Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-02-13 |
Marketing Category | NDA / NDA |
Application Number | NDA201281 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
Active Ingredient Strength | 3 mg/1; mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-02-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA201281 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-02-13 |
Marketing Category | NDA |
Application Number | NDA201281 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-02-13 |
Marketing Category | NDA |
Application Number | NDA201281 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-02-13 |
Marketing Category | NDA |
Application Number | NDA201281 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-02-13 |
Marketing End Date | 2013-07-26 |
Ingredient | Strength |
---|---|
LINAGLIPTIN | 2.5 mg/1 |
SPL SET ID: | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0146 | Jentadueto | linagliptin and metformin hydrochloride |
0597-0147 | Jentadueto | linagliptin and metformin hydrochloride |
0597-0148 | Jentadueto | linagliptin and metformin hydrochloride |
63629-6524 | Jentadueto | linagliptin and metformin hydrochloride |
0597-0270 | Jentadueto XR | linagliptin and metformin hydrochloride |
0597-0275 | Jentadueto XR | linagliptin and metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JENTADUETO 79100637 4078793 Live/Registered |
Boehringer Ingelheim International GmbH 2011-06-01 |